Tracer library / [18F](E)-PSS232

[18F](E)-PSS232

Also written as [18F](E)-PSS232
Radionuclide
F-18 t½ 109.77 min
Modality
PET
Production route
—
Stage
—
Syntheses indexed
1

What it is

Compound class
oxime-based small molecule radiotracer (fluoroethoxypropyl oxime analogue of cyclohexenone)
Target / mechanism
metabotropic glutamate receptor subtype 5 (mGlu5) PMID 28948638
Clinical application
Brain PET imaging for neuropsychiatric disorders involving mGlu5 PMID 28948638
Theranostic pair
—

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
TRACERlab FX FN
GE HealthCare
—HPLC40 ± 2%
decay-corrected
>95%mesylate precursor28948638
2018 J Labelled Comp Radiopharm
using a commercial GE TRACERlab™ FX-FN synthesizer for routine production and distribution to nearby satellite clinics - provided [18 F]2a with a radiochemical yield of 40 ± 2% (decay corrected, n = 5) at the end of synthesis

Need this precursor?We can point you to suppliers for [18F](E)-PSS232, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary); conventional nucleophilic 18F-fluorination assumed from isotope/compound class, no synthesis data confirming K222 use -> Kryptofix test (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [18F](E)-PSS232.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with F-18.
Ask a question